A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction

This study is not yet open for participant recruitment.

Study NCT01311518 Information provided by RegeneRx Biopharmaceuticals, Inc.

First Received: March 7, 2011 Last Updated: August 8, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is not yet open for participant recruitment.
Estimated Study Completion Date:	August 2012
Estimated Primary Completion Date:	June 2012 (Final data collection date for primary outcome measure)